Hindering HIV-1-fighting immune cells

Dec 14, 2009

Immune proteins called HLA molecules help to activate killer T cell responses against pathogens. But according to a study that will be published online on December 14th in the Journal of Experimental Medicine, one particular group of HLA molecules cripples this activation, perhaps explaining why HIV-infected individuals who express these HLAs progress to AIDS more rapidly than others.

AIDS develops more rapidly in individuals who express HLA B*35-Px than in those who express the highly related HLA B*35PY proteins. The new study, lead by Xu Yu at Massachusetts General Hospital, shows that B*35-Px molecules bind to and activate an inhibitory receptor on dendritic cells—cells that are needed to activate protective . These findings suggest that inhibitory dendritic should be taken into consideration during future efforts to design HIV-1 vaccines and therapies.

More information: Huang, J., et al. 2009. J. Exp. Med. doi:10.1084/jem.20091386

Source: Rockefeller University (news : web)

Explore further: Withdrawal from the evolutionary race

add to favorites email to friend print save as pdf

Related Stories

HIV pays a price for invisibility

Apr 13, 2009

Mutations that help HIV hide from the immune system undermine the virus's ability to replicate, show an international team of researchers in the April 13 issue of the Journal of Experimental Medicine. The study was publis ...

Modeling pathogen responses

Oct 12, 2007

The search for a vaccination against HIV has been in progress since 1984, with very little success. Traditional methods used for identifying potential cellular targets can be very costly and time-consuming. The key to creating ...

Genetic cause of innate resistance to HIV/AIDS

Jul 16, 2008

Some people may be naturally resistant to infection with HIV, the virus that causes AIDS. The results of a study conducted by Dr. Nicole Bernard of the Research Institute of the McGill University Health Centre (MUHC) bring ...

Recommended for you

Withdrawal from the evolutionary race

12 hours ago

In some HIV sufferers, the immune system does not fight off the immune deficiency virus. Instead, the body tolerates the pathogen. A research team headed by ETH Zurich has now determined how strongly patients ...

The genetics of coping with HIV

Sep 16, 2014

We respond to infections in two fundamental ways. One, which has been the subject of intensive research over the years, is "resistance," where the body attacks the invading pathogen and reduces its numbers. Another, which ...

Long acting HIV drugs to be developed

Sep 11, 2014

HIV drugs which only need to be taken once a month are to be developed at the University of Liverpool in a bid to overcome the problem of 'pill fatigue'.

User comments : 0